Clark Q. Pan

2.4k total citations
47 papers, 1.9k citations indexed

About

Clark Q. Pan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Clark Q. Pan has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Clark Q. Pan's work include Advanced biosensing and bioanalysis techniques (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Clark Q. Pan is often cited by papers focused on Advanced biosensing and bioanalysis techniques (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Clark Q. Pan collaborates with scholars based in United States, Germany and France. Clark Q. Pan's co-authors include Robert A. Lazarus, David S. Sigman, Qun Zhou, Huawei Qiu, Tim Edmunds, Reid C. Johnson, Anna Park, Baisong Mei, Steven E. Finkel and Jinan Feng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Clark Q. Pan

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clark Q. Pan United States 23 1.0k 397 282 233 227 47 1.9k
V M Garsky United States 23 1.7k 1.6× 305 0.8× 546 1.9× 250 1.1× 244 1.1× 37 2.5k
Jean-Philippe Stéphan France 25 1.3k 1.3× 306 0.8× 405 1.4× 299 1.3× 343 1.5× 36 2.2k
Stephen Thompson United Kingdom 23 923 0.9× 342 0.9× 152 0.5× 259 1.1× 312 1.4× 77 1.8k
Takatoshi Nakagawa Japan 23 1.4k 1.4× 230 0.6× 305 1.1× 122 0.5× 547 2.4× 53 2.0k
C. Chandra Kumar United States 24 1.8k 1.7× 144 0.4× 449 1.6× 86 0.4× 218 1.0× 43 2.5k
Christoph Kannicht Germany 24 1.0k 1.0× 232 0.6× 308 1.1× 92 0.4× 320 1.4× 65 1.9k
Zining Wu United States 22 735 0.7× 175 0.4× 172 0.6× 162 0.7× 320 1.4× 60 1.4k
George O. Lovrecz Australia 22 1.9k 1.9× 829 2.1× 991 3.5× 110 0.5× 351 1.5× 42 3.1k
Louis Fabri Australia 26 1.4k 1.4× 319 0.8× 1.1k 3.8× 174 0.7× 771 3.4× 55 2.6k
Kenji Sugita Japan 23 1.4k 1.4× 129 0.3× 538 1.9× 132 0.6× 424 1.9× 83 2.9k

Countries citing papers authored by Clark Q. Pan

Since Specialization
Citations

This map shows the geographic impact of Clark Q. Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark Q. Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark Q. Pan more than expected).

Fields of papers citing papers by Clark Q. Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clark Q. Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark Q. Pan. The network helps show where Clark Q. Pan may publish in the future.

Co-authorship network of co-authors of Clark Q. Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Clark Q. Pan. A scholar is included among the top collaborators of Clark Q. Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clark Q. Pan. Clark Q. Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Qun, Ekaterina Boudanova, Jochen Beninga, et al.. (2020). Engineered Fc-glycosylation switch to eliminate antibody effector function. mAbs. 12(1). 1814583–1814583. 11 indexed citations
2.
Jin, Shan, Brian Dwyer, Anisha Korde, et al.. (2020). Generation of FX −/− and Gmds −/− CHOZN host cell lines for the production of afucosylated therapeutic antibodies. Biotechnology Progress. 37(1). e3061–e3061. 6 indexed citations
3.
Qiu, Huawei, Ronnie R. Wei, Ekaterina Boudanova, et al.. (2019). Engineering an anti-CD52 antibody for enhanced deamidation stability. mAbs. 11(7). 1266–1275. 16 indexed citations
4.
Birrane, Gabriel, Anne P. Beigneux, Brian Dwyer, et al.. (2018). Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis. Proceedings of the National Academy of Sciences. 116(5). 1723–1732. 63 indexed citations
5.
Stefano, James E., Julie Bird, Josephine Kyazike, et al.. (2012). High-Affinity VEGF Antagonists by Oligomerization of a Minimal Sequence VEGF-Binding Domain. Bioconjugate Chemistry. 23(12). 2354–2364. 9 indexed citations
6.
Edling, Andrea E., Timothy Weeden, John L. Dzuris, et al.. (2011). Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis. Journal of Neuroimmunology. 236(1-2). 1–9. 24 indexed citations
7.
Mei, Baisong, Clark Q. Pan, Haiyan Jiang, et al.. (2010). Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment. Blood. 116(2). 270–279. 176 indexed citations
8.
Weeden, Timothy, Su Duan, Andrea E. Edling, et al.. (2010). A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity. Journal of Peptide Science. 17(1). 47–55. 6 indexed citations
9.
Wei, Ronnie R., Heather Hughes, Julie Bird, et al.. (2010). X-ray and Biochemical Analysis of N370S Mutant Human Acid β-Glucosidase. Journal of Biological Chemistry. 286(1). 299–308. 57 indexed citations
10.
Claus, Thomas H., Clark Q. Pan, Joanne Buxton, et al.. (2007). Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes. Journal of Endocrinology. 192(2). 371–380. 35 indexed citations
11.
Pan, Clark Q., Fugang Li, Irene Tom, et al.. (2006). Engineering Novel VPAC2-Selective Agonists with Improved Stability and Glucose-Lowering Activity in Vivo. Journal of Pharmacology and Experimental Therapeutics. 320(2). 900–906. 22 indexed citations
12.
Parsons, Christopher J., Blair U. Bradford, Clark Q. Pan, et al.. (2004). Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology. 40(5). 1106–1115. 155 indexed citations
13.
Pan, Clark Q., Dominick Sinicropi, & Robert A. Lazarus. (2003). Engineered Properties and Assays for Human DNase I Mutants. Humana Press eBooks. 160. 309–321. 7 indexed citations
14.
Dwyer, Mary A., Arthur Huang, Clark Q. Pan, & Robert A. Lazarus. (1999). Expression and Characterization of a DNase I-Fc Fusion Enzyme. Journal of Biological Chemistry. 274(14). 9738–9743. 12 indexed citations
15.
Pan, Clark Q. & Robert A. Lazarus. (1999). Ca2+‐dependent activity of human DNase I and its hyperactive variants. Protein Science. 8(9). 1780–1788. 21 indexed citations
16.
Pan, Clark Q. & Robert A. Lazarus. (1998). Hyperactivity of Human DNase I Variants. Journal of Biological Chemistry. 273(19). 11701–11708. 35 indexed citations
17.
18.
Pan, Clark Q., et al.. (1998). Improved Potency of Hyperactive and Actin-resistant Human DNase I Variants for Treatment of Cystic Fibrosis and Systemic Lupus Erythematosus. Journal of Biological Chemistry. 273(29). 18374–18381. 30 indexed citations
19.
Pan, Clark Q., Steven E. Finkel, Sarah E. Cramton, et al.. (1996). Variable Structures of Fis-DNA Complexes Determined by Flanking DNA – Protein Contacts. Journal of Molecular Biology. 264(4). 675–695. 128 indexed citations
20.
Pan, Clark Q., Ralf Landgraf, & David S. Sigman. (1995). Drosophilaengrailed‐1, 10‐phenanthroline chimeras as probes of homeodomain‐DNA complexes. Protein Science. 4(11). 2279–2288. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V M Garsky Breakdown of academic impact, for papers by Jean-Philippe Stéphan Breakdown of academic impact, for papers by Stephen Thompson Breakdown of academic impact, for papers by Takatoshi Nakagawa Breakdown of academic impact, for papers by C. Chandra Kumar Breakdown of academic impact, for papers by Christoph Kannicht Breakdown of academic impact, for papers by Zining Wu Breakdown of academic impact, for papers by George O. Lovrecz Breakdown of academic impact, for papers by Louis Fabri Breakdown of academic impact, for papers by Kenji Sugita
Rankless by CCL
2026